secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2026-10-21T10:01:36+00:00
Accession:  0001156039-26-000068
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Elevance Q3 revenue $50.4B, adjusted EPS $6.99; raises FY26 adjusted EPS guidance to at least $29.00
--------------------------------------------------------------------------------

- Q3 operating revenue $50.4B, up 0.7% YoY; diluted EPS $6.27 and adjusted EPS $6.99, including a net non-operating benefit of $1.85 per share.
- FY2026 guidance raised to at least $22.00 diluted EPS and at least $29.00 adjusted EPS, cash flow at least $6.5B; 2027 adjusted EPS growth seen at least 12% off $26.75 baseline.
- Health Benefits revenue $43.4B (+3%) but operating gain fell to $0.4B from $0.6B on targeted investments; margin 1.0% vs 1.4%; membership 44.9M, down 487k YoY.
- Carelon revenue $19.3B (+5%), operating gain $0.9B (+17%) on risk-based solutions and specialty pharmacy; benefit expense ratio improved 70 bps to 90.6%.
- Q4 dividend $1.72/share payable Dec 18, 2026 to holders of record Dec 4; Q3 buybacks 0.8M shares for $330M at $398.75 average; $5.0B authorization remains.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000068/0001156039-26-000068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000068/elv-20261021.htm
  HTML page:      https://secwatch.observer/filing/0001156039-26-000068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer